HSCS (HeartSciences) Other Long Term Assets: $0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSCS HeartSciences Inc HSCS
27 GF Score
Price $2.07
GF Value $0.55
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is HeartSciences Other Long Term Assets?

HeartSciences HSCS -0.49% 27 Other Long Term Assets is $0.00 Mil as of Apr. 2026. GuruFocus rates HSCS with a GF Score™ of 27/100 and a GF Value™ of $0.55 (Significantly Overvalued). The stock has 8 warning signs investors should review.

HeartSciences's other long-term assets for the quarter that ended in Apr. 2026 was $0.00 Mil.

HeartSciences's quarterly other long-term assets increased from Oct. 2025 ($0.00 Mil) to Jan. 2026 ($0.00 Mil) and increased from Jan. 2026 ($0.00 Mil) to Apr. 2026 ($0.00 Mil).

HeartSciences's annual other long-term assets increased from Apr. 2024 ($0.00 Mil) to Apr. 2025 ($0.00 Mil) but then declined from Apr. 2025 ($0.00 Mil) to Apr. 2026 ($0.00 Mil).

HeartSciences Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for HeartSciences's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Other Long Term Assets Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Long Term Assets
Get a 7-Day Free Trial -0.00 -0.00 0.00 0.00 0.00

HeartSciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
HSCS
27GF Score
HeartSciences Inc HSCS
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.00 Mil mean?
HeartSciences (HSCS) has a Other Long Term Assets of $0.00 Mil as of Apr. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on HeartSciences and its competitors.
Is HeartSciences' Other Long Term Assets too high?
HeartSciences' current Other Long Term Assets is $0.00 Mil. Overall, HeartSciences has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Other Long Term Assets compare to CODX and NVNO?
HeartSciences' Other Long Term Assets of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Devices & Instruments company?
A good Other Long Term Assets depends on the Medical Devices & Instruments industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on HeartSciences and its competitors. HeartSciences's current Other Long Term Assets is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.55, compared to a current price of $2.07 — trading 276.4% above its estimated fair value. The current Other Long Term Assets is $0.00 Mil. HeartSciences' overall GF Score™ is 27/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For HeartSciences (HSCS), the current Other Long Term Assets is $0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.07 is trading 276.4% above its estimated GF Value™ of $0.55. GuruFocus considers HeartSciences to be Significantly Overvalued.

Key valuation signals for HSCS:

  • Other Long Term Assets: $0.00 Mil
  • GF Value™: $0.55 vs. price of $2.07 (276.4% above fair value)
  • GF Score™: 27/100 with 8 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
27GF Score

Get the complete analysis for HSCS

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.07
Price
$0.55
GF Value